Feasibility Study of Umbilical Cord Tissue Derived Mesenchymal Stem Cells (UC-MSC) in Disease Modifying Anti-Rheumatic Drugs (DMARD) Resistant Rheumatoid Arthritis
Phase of Trial: Phase I/II
Latest Information Update: 12 Aug 2017
At a glance
- Drugs Cord blood stem cell therapy (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- Sponsors Translational Biosciences
- 10 Jun 2017 Biomarkers information updated
- 26 Apr 2017 Planned End Date changed from 1 Dec 2018 to 1 Feb 2019.
- 26 Apr 2017 Planned primary completion date changed from 1 Apr 2018 to 1 Aug 2018.